Cite

HARVARD Citation

    von Rosenstiel, P. et al. (n.d.). P1‐041: 24‐MONTH ANALYSIS OF APOE ε4 CARRIERS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB. Alzheimer's & dementia. p. P283. [Online]. 
  
Back to record